In the fast-evolving world of pharmaceutical sciences, Unit 1 introduces students to some of the most clinically important drug classes—antihistamines, proton pump inhibitors, H2 blockers, and anti-neoplastic agents. These medicines play a fundamental role in managing allergies, gastric acid disorders, and even life-threatening cancers. Understanding their chemistry, mechanisms, and therapeutic relevance provides an essential foundation for future pharmacists and healthcare professionals.

Download UNIT 1 – Pharmacognosy’s Expanding Role in Modern and Traditional Healing Systems Notes

Get simplified revision notes for this unit:

⬇️

Download Unit 1 Notes PDF

Histamine and Its Receptors: A Complex Biological Signaling System

Histamine is a naturally occurring biogenic amine stored in mast cells, basophils, brain neurons, and gastric mucosa. It is released during allergic reactions, inflammatory responses, and physiological processes like gastric acid secretion.

Histamine acts through H1, H2, H3, and H4 receptors, each distributed across different organs:

H1 receptors: Smooth muscles, endothelium, CNS—linked to allergy symptoms such as itching, vasodilation, and bronchoconstriction.
H2 receptors: Gastric parietal cells—responsible for regulating gastric acid secretion.
H3 receptors: Predominantly in the CNS—modulating neurotransmitter release.
H4 receptors: Found in blood cells—associated with immune system regulation.

This receptor-based understanding paved the way for designing targeted antihistamines and gastric acid–reducing drugs.

H1 Antagonists: The Frontline Defense Against Allergy

H1-antihistamines block H1 receptors and prevent classic allergic symptoms like rhinorrhea, itching, urticaria, and motion sickness. They are broadly categorized into first-generation (sedative) and second-generation (non-sedative) agents.

First-Generation H1 Antagonists

These drugs readily cross the blood–brain barrier, often causing sedation but offering strong anti-allergic and antiemetic effects.

Common examples include:

Diphenhydramine hydrochloride and Doxylamine succinate, widely used for allergy and insomnia relief.
Dimenhydrinate, a popular anti-motion-sickness agent.
Chlorpheniramine maleate, Triprolidine hydrochloride, and Promethazine hydrochloride, essential for treating allergic rhinitis and nausea.
Meclizine hydrochloride and Buclizine hydrochloride, effective in vertigo and motion sickness.
Cyproheptadine hydrochloride, known for appetite-stimulating properties.
Clemastine fumarate, Chlorcyclizine, Phenindamine tartrate, Trimeprazine, and Diphenylpyraline hydrochloride, used for symptomatic allergy management.

Second-Generation H1 Antagonists

These newer agents do not easily cross the blood–brain barrier, reducing sedation.

Astemizole, an early non-sedating antihistamine (now used cautiously due to cardiac risks).
Loratadine, Cetirizine, and Levocetirizine, widely used for chronic allergic conditions.
Cromolyn sodium, though not an antihistamine, stabilizes mast cells and prevents histamine release—making it crucial in asthma and allergic prophylaxis.

Together, these agents have revolutionized allergy treatment, offering options tailored to patient needs.

H2 Antagonists: Reducing Gastric Acid at Its Source

H2-blockers act by inhibiting H2 receptors on gastric parietal cells, thereby reducing acid secretion. They are well-established treatments for peptic ulcer disease, GERD, gastritis, and Zollinger–Ellison syndrome.

Key drugs include:

Cimetidine – the first clinically used H2 blocker, though known for drug-interaction issues.
Ranitidine – once widely prescribed, now withdrawn in many regions due to safety concerns.
Famotidine – a safer, highly potent option still commonly used.

These agents marked a major milestone in gastroenterology by offering effective, non-surgical treatment for acid-related disorders.

Proton Pump Inhibitors (PPIs): The Gold Standard in Acid Suppression

PPIs inhibit the H⁺/K⁺ ATPase enzyme (the gastric proton pump) and are more potent than H2 blockers. They provide long-lasting acid suppression and are essential in:

Peptic and duodenal ulcers
GERD and erosive esophagitis
H. pylori therapy regimens
Prevention of NSAID-induced gastritis

Common PPIs include:

Omeprazole – the first agent in this class.
Lansoprazole, Rabeprazole, and Pantoprazole – popular choices for long-term therapy with excellent safety profiles.

Anti-Neoplastic Agents: Targeting Cancer at the Molecular Level

Cancer therapy involves multiple drug classes, each acting on different phases of the cell cycle. Anti-neoplastic drugs introduced in Unit 1 cover some of the most widely used chemotherapeutic categories.

Alkylating Agents

These drugs form covalent bonds with DNA, preventing replication and triggering cell death.

Mechlorethamine, the first nitrogen mustard used in cancer.
Cyclophosphamide – a cornerstone drug in many cancer regimens.
Melphalan, Chlorambucil, Busulfan, and Thiotepa – used across leukemia, lymphoma, and solid tumors.

Antimetabolites

These mimic natural metabolites and disrupt DNA or RNA synthesis.

Widely used antimetabolites include:

Mercaptopurine and Thioguanine – purine antagonists.
Fluorouracil and Floxuridine – pyrimidine analogues essential in colorectal and breast cancers.
Cytarabine – a key drug in acute leukemia.
Methotrexate and Azathioprine – folate antagonists with both anticancer and immunosuppressive roles.

Antibiotics with Anticancer Activity

These are cytotoxic natural products from microorganisms.

Dactinomycin, Daunorubicin, Doxorubicin, and Bleomycin are central agents used in sarcomas, leukemias, lymphomas, and testicular cancer.

Plant-derived Anti-Neoplastics

Nature remains a powerful source of chemotherapeutics.

Etoposide – inhibits topoisomerase II.
Vinblastine sulphate and Vincristine sulphate – disrupt microtubules and inhibit mitosis.

Miscellaneous Agents

Unique drugs with distinct mechanisms include:

Cisplatin – a platinum-based DNA crosslinker widely used in solid tumors.
Mitotane – a specialized drug for adrenal cortical carcinoma.